SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-113541
Filing Date
2016-04-22
Accepted
2016-04-22 16:35:31
Documents
1
Period of Report
2016-04-18

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4503
  Complete submission text file 0001104659-16-113541.txt   5940
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3122 STERLING CIRCLE SUITE 200 BOULDER CO 80301
Business Address
Rodman David Malcom (Reporting) CIK: 0001672659 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 161587042